Despite the U.S. Department of Justice’s decision to terminate its China Initiative in February 2022, recent legal actions suggest the principles behind the initiative remain active. A recent settlement under the False Claims Act with the Cleveland Clinic Foundation underscores this ongoing enforcement. The settlement indicates that prosecutors continue to target research institutions linked to previously scrutinized employees. According to attorneys at Benesch, this development highlights how the objectives of the China Initiative are still being pursued in a civil capacity.
For legal professionals interested in the details of this settlement and its implications, more information can be found on Law360.